LONDON -- For chronic asthma, twice-daily use of salmeterol (Serevent) was associated with small but significant increases in serious adverse events, a meta-analysis showed.
Salmeterol (Serevent) Increases Serious Adverse Events in Chroni...Courtesy MedPage Today Allergy & Immunology Thu, 07/17/2008 - 08:06
LONDON -- For chronic asthma, twice-daily use of salmeterol (Serevent) was associated with small but significant increases in serious adverse events, a meta-analysis showed. More related itemsGlucose Control No Guarantee Against HF (CME/CE)
Plavix-Immune Platelets Predict Worse Outcomes...
Kids at Increased Risk with Long-Acting Beta-Agonists...
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
|
Popular by tags WeekMonth |
Post new comment